Skip to content

LAB

Standard BioTools Inc.

NASDAQ · Healthcare · Medical - Devices · US

$0.69
+1.72%
Ask drillr
Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
P/E (Fwd)
EV/EBITDA
2.0x
Market Cap
$269.11M
RSI (14)
40.2
1D Return
+1.72%
YTD Return
−47.73%
SummaryUpdated Jun 1, 2026

Standard BioTools Inc. (NASDAQ:LAB) is a life sciences tools company that was founded in 1999 as Fluidigm Corporation and rebranded to its current name in April 2022. The company designs, manufactures, and markets specialized scientific instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. Standard BioTools underwent a significant transformation in January 2024 when it merged with SomaLogic, a proteomics company, creating a diversified platform focused on multi-omics research tools. The company is headquartered in South San Francisco, California, and serves academic research institutions, pharmaceutical companies, biotechnology firms, and clinical laboratories globally.

Similar companies

Latest newsMore news →